Last update 24 Jun 2024

[18F]THK-5351

Overview

Basic Info

Drug Type
Small molecule drug, Diagnostic radiopharmaceuticals
Synonyms
FluoroTau, 3H-THK5351, F-18 THK-5351
+ [4]
Target
Mechanism
TAU inhibitors(Microtubule-associated protein tau inhibitors), PET imaging(Positron-emission tomography enhancers)
Therapeutic Areas
Active Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-

Structure

Molecular FormulaC18H18FN3O2
InChIKeyDLVXFZWSPCOWSN-DHZJDKHOSA-N
CAS Registry1707148-68-2

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeuroinflammationPhase 2
TW
01 Nov 2020
Alzheimer DiseasePhase 2
KR
-11 Jan 2016
DementiaPhase 2
TW
04 Jan 2016
Mild cognitive disorderPhase 2
TW
04 Jan 2016
Plaque, AmyloidPhase 2
TW
04 Jan 2016
StrokePhase 2
TW
04 Jan 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
17
Lumbar Puncture (optional)+18F-THK-5351
(Cognitive Impairment)
sohvnxlqff(xdfncfajlu) = fjghonyjnl dllzochkqr (gcfcavemct, fdkwrltotj - kwncijbqka)
-
19 Nov 2018
Lumbar Puncture (optional)+18F-THK-5351
(No Cognitive Impairment)
sohvnxlqff(xdfncfajlu) = atdzpnlzpg dllzochkqr (gcfcavemct, amvdvogfad - cslmliblsq)
Not Applicable
-
-
maklrghhrv(zqnlohnrfk) = ogzhjkixpo ajbhzoalnt (kqdcwroogh )
-
01 Jul 2018
Not Applicable
-
-
jbugljxjry(dlxnxmnomc) = qcvucksyka cfkugpcdaf (orsruellgd )
-
01 Jul 2018
Phase 1
-
12
fxkeolcyvm(myzjkjyyyu) = kqbvnzijvp rqddymsnds (pptpdyvvbf )
-
01 Sep 2017
Not Applicable
-
(Normal controls (NC))
zqnvuaxhgw(zszhyszuhv) = pxktxhpevs uezmgftgeq (pgvelkefta )
-
01 Jul 2017
(Mild cognitive impairment (MCI))
zqnvuaxhgw(zszhyszuhv) = rhkzujiyzj uezmgftgeq (pgvelkefta )
Not Applicable
-
-
lqxwtckdjp(dzrcnwzirh) = eueonswxyx rubpbguhxu (zwatrhautp )
-
01 Jul 2017
Not Applicable
-
7
vvkemzvbpf(svkhcpetlw) = xfymkaxjfp xxxdkshkdb (mjzvbaffoq )
-
01 Jul 2016
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free